| Revenue | NOK 0 | — |
| EBITDA | NOK -584K | -60762% |
| Net profit | NOK -674K | -70137% |
| Total assets | NOK 100K | -87% |
| Equity | NOK -624K | -1335% |
| Employees | 0 | — |
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 | −0 |
| EBITDA | −35 | 0 | −3 | −2 | −1 | −584 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 |
| EBIT | −35 | 0 | −3 | −2 | −1 | −584 |
| Net financials | 0 | 0 | 0 | 0 | 0 | −90 |
| Profit before tax | −35 | 0 | −3 | −2 | −1 | −674 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 |
| Net profit | −35 | 0 | −3 | −2 | −1 | −674 |
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Total assets | 790 | 0 | 753 | 769 | 774 | 100 |
| Equity | 59 | 90 | 53 | 51 | 51 | −624 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 731 | 0 | 700 | 718 | 724 | 724 |
| Total debt | 731 | 0 | 700 | 718 | 724 | 724 |
No data on file.
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2021 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 20.0% | 20.0% | 2022 | |
| Individual | 20.0% | 20.0% | 2022 | |
Norsk Medisinsk Termografi As | Company | 20.0% | 20.0% | 2022 |
| Individual | 20.0% | 20.0% | 2024 | |
| Individual | 20.0% | 20.0% | 2022 |
| Person | Role here | Other companies |
|---|---|---|
| Jan Ove Augustus Weidemann Brevad | Board of Directors | 0 companies |